We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $60.9K | 0.02% |
855
+4
| +0.5% | +$279 |
2019 Q4
26 quarters
|
|
152
Invesco Oil & Gas Services ETF
PXJ
$128M
| $60.4K | 0.02% |
1,566
+5
| +0.3% | +$215 |
2021 Q4
18 quarters
|
|
153
iShares MSCI EAFE Growth ETF
EFG
$14.8B
| $60.2K | 0.02% |
484
-14
| -3% | -$1.69K |
2019 Q4
26 quarters
|
|
154
Southern Company
SO
$107B
| $59.6K | 0.02% |
623
| – | – |
2019 Q4
26 quarters
|
|
155
Tactile Systems Technology
TCMD
$536M
| $59.6K | 0.02% |
2,000
| – | – |
2024 Q3
7 quarters
|
|
156
Kinross Gold
KGC
$26.5B
| $57.8K | 0.02% |
2,449
+3
| +0.1% | +$88 |
2019 Q4
26 quarters
|
|
157
Mastercard
MA
$546B
| $57.3K | 0.02% |
112
-99
| -47% | -$49.4K |
2019 Q4
26 quarters
|
|
158
Remitly
RELY
$5.25B
| $57.1K | 0.02% |
2,550
| – | – |
2025 Q4
2 quarters
|
|
159
Bank of America
BAC
$354B
| $56.7K | 0.02% |
995
-43
| -4% | -$2.29K |
2019 Q4
26 quarters
|
|
160
NEOS S&P 500 High Income ETF
SPYI
$12.2B
| $56.7K | 0.02% |
1,067
-857
| -45% | -$45.1K |
2025 Q1
5 quarters
|
|
161
iShares US Healthcare Providers ETF
IHF
$1.43B
| $55.3K | 0.02% |
1,000
-509
| -34% | -$25.2K |
2019 Q4
26 quarters
|
|
162
Realty Income
O
$53.8B
| $55.1K | 0.02% |
889
-470
| -35% | -$29.3K |
2023 Q3
11 quarters
|
|
163
Lockheed Martin
LMT
$139B
| $54.8K | 0.02% |
108
+1
| +0.9% | +$541 |
2019 Q4
26 quarters
|
|
164
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $54.1K | 0.02% |
654
-79
| -11% | -$6.3K |
2019 Q4
26 quarters
|
|
165
QuidelOrtho
QDEL
$942M
| $54.1K | 0.02% |
3,090
-1,200
| -28% | -$15.8K |
2019 Q4
26 quarters
|
|
166
Vanguard FTSE All-World ex-US ETF
VEU
$66.3B
| $53.5K | 0.02% |
639
+152
| +31% | +$12.4K |
2021 Q2
20 quarters
|
|
167
Boeing
BA
$149B
| $51.7K | 0.02% |
239
+20
| +9% | +$4.45K |
2020 Q1
25 quarters
|
|
168
Schwab US Large- Cap ETF
SCHX
$73.6B
| $51.5K | 0.02% |
1,749
+4
| +0.2% | +$114 |
2019 Q4
26 quarters
|
|
169
Marsh
MRSH
$94.2B
| $51.3K | 0.02% |
308
| – | – |
2019 Q4
26 quarters
|
|
170
Bristol-Myers Squibb
BMY
$126B
| $49.7K | 0.02% |
863
-233
| -21% | -$13.4K |
2019 Q4
26 quarters
|
|
171
Vanguard Dividend Appreciation ETF
VIG
$114B
| $49.4K | 0.02% |
209
+1
| +0.5% | +$230 |
2023 Q4
10 quarters
|
|
172
Palvella Therapeutics
PVLA
$1.8B
| $49.2K | 0.02% |
322
| – | – |
2026 Q1
1 quarter
|
|
173
Fidelity MSCI Financials Index ETF
FNCL
$2.31B
| $46.8K | 0.02% |
611
| – | – |
2019 Q4
26 quarters
|
|
174
VanEck Oil Services ETF
OIH
$1.89B
| $46.5K | 0.02% |
125
| – | – |
2021 Q4
18 quarters
|
|
175
Strategy Inc
MSTR
$61.8B
| $46.2K | 0.02% |
532
| – | – |
2022 Q3
15 quarters
|
|
Similar funds
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.